Inflammatory pseudotumour is a generic term applied to a variety of neoplastic and non-
neoplastic entities that share a common histological appearance, namely a cytologically …

Inflammatory myofibroblastic tumor (IMT) is a neoplasm that typically occurs in children. The
genetic landscape of this tumor is incompletely understood and therapeutic options are …

Inflammatory myofibroblastic tumor (IMT) is a neoplasm of intermediate biologic potential. In
this study, we report a subset of IMTs with histologic atypia and/or clinical aggressiveness …

Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm with intermediate malignancy
characterized by a propensity for recurrence but a low metastatic rate. Diagnostic challenges …

Background An inflammatory myofibroblastic tumour (IMFT) is a rare mesenchymal
neoplasm characterised by anaplastic lymphoma kinase (ALK) gene rearrangements. We …

Aims The aim of this study was to elucidate the pathological features of inflammatory
myofibroblastic tumour (IMT) with gene rearrangement other than ALK. Methods and results …

This edition stresses not just the diagnostic cytological features of the various conditions
encountered, but also the diagnostic pitfalls and the grey areas between so as to enable the …

Idiopathic retroperitoneal fibrosis (IRF) is a rare disease often causing obstructive uropathy.
We evaluated the clinicopathologic features of 24 patients with IRF to characterize the …

Inflammatory myofibroblastic tumors of the uterus are rare, and although most have a
favorable prognosis, a small subset exhibit extrauterine disease, recur, or cause death. In …

Crizotinib, an inhibitor of anaplastic lymphoma kinase (ALK), MET, and ROS1, is approved
for treatment of patients with ALK‐positive or ROS1‐positive advanced non‐small‐cell lung …